A closed-loop insulin delivery system, combining a continuous glucose monitoring device with an insulin pump, was approved for U.S. marketing Wednesday, the FDA announced. Medtronic's MinMed 670G hybrid system is the first such device to be approved, the agency said.
Trending:
'Bionic Pancreas' OK'd